Prostatic alpha-linolenic acid (ALA) is positively associated with aggressive prostate cancer: a relationship which may depend on genetic variation in ALA metabolism.

Previous observational studies have reported associations between prostate cancer and alpha-linolenic acid (ALA). However, few investigations have been able to study this relationship prospectively and in well-controlled settings. Moreover, no studies have determined whether single nucleotide polymo...

Full description

Bibliographic Details
Main Authors: Maria Azrad, Kui Zhang, Robin T Vollmer, John Madden, Thomas J Polascik, Denise C Snyder, Mack T Ruffin, Judd W Moul, Dean Brenner, Robert W Hardy, Wendy Demark-Wahnefried
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3532426?pdf=render
_version_ 1828406929566728192
author Maria Azrad
Kui Zhang
Robin T Vollmer
John Madden
Thomas J Polascik
Denise C Snyder
Mack T Ruffin
Judd W Moul
Dean Brenner
Robert W Hardy
Wendy Demark-Wahnefried
author_facet Maria Azrad
Kui Zhang
Robin T Vollmer
John Madden
Thomas J Polascik
Denise C Snyder
Mack T Ruffin
Judd W Moul
Dean Brenner
Robert W Hardy
Wendy Demark-Wahnefried
author_sort Maria Azrad
collection DOAJ
description Previous observational studies have reported associations between prostate cancer and alpha-linolenic acid (ALA). However, few investigations have been able to study this relationship prospectively and in well-controlled settings. Moreover, no studies have determined whether single nucleotide polymorphisms (SNPs) that influence ALA metabolism are associated with this common cancer. The purpose of this study was to explore associations between prostatic levels of ALA, SNPs and prostate cancer-specific biomarkers in samples collected from a previous randomized clinical trial conducted using a presurgical model and which tested the effects of flaxseed supplementation, a rich source of ALA, prior to prostatectomy (n = 134). Serum prostate-specific antigen (PSA) was determined and immunohistochemistry was used to assess tumor proliferation rate (Ki67). Prostatic ALA was determined with gas chromatography. Seven previously identified SNPs associated with delta-6 desaturase activity (rs99780, rs174537, rs174545, rs174572, rs498793, rs3834458 and rs968567) were tested for associations with prostatic ALA, PSA and Ki67. Despite consuming seven times more ALA per day, men in the flaxseed arm had similar amounts of prostatic ALA relative to men not consuming flaxseed. In unadjusted analysis, there were significant positive associations between prostatic ALA and PSA (ρ = 0.191, p = 0.028) and Ki67 (ρ = 0.186, p = 0.037). After adjusting for covariates (flaxseed, age, race, BMI and statin-use) the association between ALA and PSA remained (p = 0.004) but was slightly attenuated for Ki67 (p = 0.051). We did not observe associations between any of the SNPs studied and prostatic ALA; however, in models for PSA there was a significant interaction between rs498793 and ALA and for Ki67 there were significant interactions with ALA and rs99780 and rs174545. Independent and inverse associations were observed between rs174572 and Ki67. This study provides evidence that prostatic ALA, independent of the amount of ALA consumed, is positively associated with biomarkers of aggressive prostate cancer and that genetic variation may modify this relationship.
first_indexed 2024-12-10T11:18:32Z
format Article
id doaj.art-fdb2465e895943b5b751dee9b718457e
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T11:18:32Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-fdb2465e895943b5b751dee9b718457e2022-12-22T01:51:04ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01712e5310410.1371/journal.pone.0053104Prostatic alpha-linolenic acid (ALA) is positively associated with aggressive prostate cancer: a relationship which may depend on genetic variation in ALA metabolism.Maria AzradKui ZhangRobin T VollmerJohn MaddenThomas J PolascikDenise C SnyderMack T RuffinJudd W MoulDean BrennerRobert W HardyWendy Demark-WahnefriedPrevious observational studies have reported associations between prostate cancer and alpha-linolenic acid (ALA). However, few investigations have been able to study this relationship prospectively and in well-controlled settings. Moreover, no studies have determined whether single nucleotide polymorphisms (SNPs) that influence ALA metabolism are associated with this common cancer. The purpose of this study was to explore associations between prostatic levels of ALA, SNPs and prostate cancer-specific biomarkers in samples collected from a previous randomized clinical trial conducted using a presurgical model and which tested the effects of flaxseed supplementation, a rich source of ALA, prior to prostatectomy (n = 134). Serum prostate-specific antigen (PSA) was determined and immunohistochemistry was used to assess tumor proliferation rate (Ki67). Prostatic ALA was determined with gas chromatography. Seven previously identified SNPs associated with delta-6 desaturase activity (rs99780, rs174537, rs174545, rs174572, rs498793, rs3834458 and rs968567) were tested for associations with prostatic ALA, PSA and Ki67. Despite consuming seven times more ALA per day, men in the flaxseed arm had similar amounts of prostatic ALA relative to men not consuming flaxseed. In unadjusted analysis, there were significant positive associations between prostatic ALA and PSA (ρ = 0.191, p = 0.028) and Ki67 (ρ = 0.186, p = 0.037). After adjusting for covariates (flaxseed, age, race, BMI and statin-use) the association between ALA and PSA remained (p = 0.004) but was slightly attenuated for Ki67 (p = 0.051). We did not observe associations between any of the SNPs studied and prostatic ALA; however, in models for PSA there was a significant interaction between rs498793 and ALA and for Ki67 there were significant interactions with ALA and rs99780 and rs174545. Independent and inverse associations were observed between rs174572 and Ki67. This study provides evidence that prostatic ALA, independent of the amount of ALA consumed, is positively associated with biomarkers of aggressive prostate cancer and that genetic variation may modify this relationship.http://europepmc.org/articles/PMC3532426?pdf=render
spellingShingle Maria Azrad
Kui Zhang
Robin T Vollmer
John Madden
Thomas J Polascik
Denise C Snyder
Mack T Ruffin
Judd W Moul
Dean Brenner
Robert W Hardy
Wendy Demark-Wahnefried
Prostatic alpha-linolenic acid (ALA) is positively associated with aggressive prostate cancer: a relationship which may depend on genetic variation in ALA metabolism.
PLoS ONE
title Prostatic alpha-linolenic acid (ALA) is positively associated with aggressive prostate cancer: a relationship which may depend on genetic variation in ALA metabolism.
title_full Prostatic alpha-linolenic acid (ALA) is positively associated with aggressive prostate cancer: a relationship which may depend on genetic variation in ALA metabolism.
title_fullStr Prostatic alpha-linolenic acid (ALA) is positively associated with aggressive prostate cancer: a relationship which may depend on genetic variation in ALA metabolism.
title_full_unstemmed Prostatic alpha-linolenic acid (ALA) is positively associated with aggressive prostate cancer: a relationship which may depend on genetic variation in ALA metabolism.
title_short Prostatic alpha-linolenic acid (ALA) is positively associated with aggressive prostate cancer: a relationship which may depend on genetic variation in ALA metabolism.
title_sort prostatic alpha linolenic acid ala is positively associated with aggressive prostate cancer a relationship which may depend on genetic variation in ala metabolism
url http://europepmc.org/articles/PMC3532426?pdf=render
work_keys_str_mv AT mariaazrad prostaticalphalinolenicacidalaispositivelyassociatedwithaggressiveprostatecancerarelationshipwhichmaydependongeneticvariationinalametabolism
AT kuizhang prostaticalphalinolenicacidalaispositivelyassociatedwithaggressiveprostatecancerarelationshipwhichmaydependongeneticvariationinalametabolism
AT robintvollmer prostaticalphalinolenicacidalaispositivelyassociatedwithaggressiveprostatecancerarelationshipwhichmaydependongeneticvariationinalametabolism
AT johnmadden prostaticalphalinolenicacidalaispositivelyassociatedwithaggressiveprostatecancerarelationshipwhichmaydependongeneticvariationinalametabolism
AT thomasjpolascik prostaticalphalinolenicacidalaispositivelyassociatedwithaggressiveprostatecancerarelationshipwhichmaydependongeneticvariationinalametabolism
AT denisecsnyder prostaticalphalinolenicacidalaispositivelyassociatedwithaggressiveprostatecancerarelationshipwhichmaydependongeneticvariationinalametabolism
AT macktruffin prostaticalphalinolenicacidalaispositivelyassociatedwithaggressiveprostatecancerarelationshipwhichmaydependongeneticvariationinalametabolism
AT juddwmoul prostaticalphalinolenicacidalaispositivelyassociatedwithaggressiveprostatecancerarelationshipwhichmaydependongeneticvariationinalametabolism
AT deanbrenner prostaticalphalinolenicacidalaispositivelyassociatedwithaggressiveprostatecancerarelationshipwhichmaydependongeneticvariationinalametabolism
AT robertwhardy prostaticalphalinolenicacidalaispositivelyassociatedwithaggressiveprostatecancerarelationshipwhichmaydependongeneticvariationinalametabolism
AT wendydemarkwahnefried prostaticalphalinolenicacidalaispositivelyassociatedwithaggressiveprostatecancerarelationshipwhichmaydependongeneticvariationinalametabolism